These findings propose to consider the multifactorial ABCG2 molecule as novel EMT marker and to further study its functional relevance for EMT program in lung cancer in relation to the sphingolipid-associated mechanisms and the multidrug resistance regulation as assessed in [43, 44]. Here, ABCG2 is linked to lung carcinoma.